Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVLIMID for Plasma cell myeloma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7,122 adverse event reports in the FDA FAERS database where REVLIMID was used for Plasma cell myeloma.

Most Reported Side Effects for REVLIMID

Side Effect Reports % Deaths Hosp.
Pneumonia 652 7.3% 85 589
Plasma cell myeloma 632 7.1% 241 184
Death 565 6.4% 564 51
Diarrhoea 508 5.7% 20 207
Thrombosis 484 5.5% 4 165
Fatigue 448 5.1% 17 149
Platelet count decreased 362 4.1% 9 112
Full blood count decreased 352 4.0% 6 172
Deep vein thrombosis 332 3.7% 6 154
Pancytopenia 319 3.6% 20 91
Rash 310 3.5% 11 88
Anaemia 286 3.2% 28 145
White blood cell count decreased 284 3.2% 4 102
Neutropenia 253 2.9% 33 93
Asthenia 239 2.7% 17 136

Other Indications for REVLIMID

Myelodysplastic syndrome (835) Chronic lymphocytic leukaemia (121) Lymphoma (121) Product used for unknown indication (90) Mantle cell lymphoma (76) 5q minus syndrome (72) Acute myeloid leukaemia (56) Amyloidosis (56) Myelofibrosis (52) B-cell lymphoma (41)

Other Drugs Used for Plasma cell myeloma

LENALIDOMIDE (273,951) POMALIDOMIDE (81,096) DEXAMETHASONE (49,067) BORTEZOMIB (31,567) DARATUMUMAB (19,119) IXAZOMIB (17,602) CARFILZOMIB (15,333) THALIDOMIDE (10,689) CYCLOPHOSPHAMIDE (9,148) SELINEXOR (5,659)

Related Pages

REVLIMID Full Profile All Plasma cell myeloma Drugs REVLIMID Demographics REVLIMID Timeline